| |
|
|
|
Cytosorbents Corporation  
|
|
6.86 -0.18 (-0.03%) |
04-18 16:00 |
|
Open: |
7.07 |
Pre close: |
7.04 |
Target:
|
9.06 
|
|
High: |
7.08 |
Low: |
6.81 |
Resistance:
|
7.76
8.34
|
|
Volume: |
155,314 |
Market Cap: |
219M |
Support:
|
6.81
5.67
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.05
|
MACD |
MACD(12,26):
|
-0.20 |
|
MA(20): |
7.39 |
Signal(12,26,9): |
-0.15 |
|
MA(100): |
8.06 |
Stochastic Oscillator |
%K(14,3):
|
9.78  |
|
MA(250): |
9.94 |
%D(3): |
10.39 |
|
Average Volume(K) |
3-Month: |
13146
|
52-Week |
High:
|
14.95 |
|
10-Days: |
11184 |
Low: |
6.70 |
|
RSI |
RSI(14):
|
34.37 |
Change(%): |
-10.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.560 |
Return on Equity (ttm) |
-126.6 |
Shares Out. (M) |
31.86 |
|
EPS Est. Current Year |
-0.270 |
Return on Assets (ttm) |
-60.5 |
Shares Float (M) |
12.64 |
|
EPS Est. Next Year |
-0.280 |
PEG Ratio |
0.00 |
% Held by Insiders |
64.00 |
|
EPS Est. Next Quarter |
-0.110 |
Qtrly Rev. Growth |
30.9 |
% Held by Institutions |
41.90 |
|
Forward EPS |
-0.120 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
14.000 |
EBITDA (p.s.) |
0.000 |
P/E |
-12.25 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.49 |
|
Profit Margin |
-89.95 |
Operating Cash Flow
(M) |
-10.84 |
P/S |
299396704.00 |
|
Operating Margin |
-69.25 |
Levered Free Cash Flow
(M) |
-7.31 |
P/CF |
-20.16 |
|
|
|
|
|
|
